期刊文献+

18F-FDG PET/CT三种评价方法在初治弥漫大B细胞淋巴瘤患者骨髓受累中的诊断价值 被引量:4

Diagnostic value of three evaluation methods of 18F-FDG PET/CT in detecting bone marrow infiltration in patients with newly diagnosed diffuse large B-cell lymphoma
原文传递
导出
摘要 目的 探讨18F-FDG PET/CT的三种评价方法在弥漫大B细胞淋巴瘤(DLBCL)患者骨髓受累中的诊断价值.方法 对2012年7月至2014年6月的77例初治DLBCL患者资料进行回顾性分析,所有患者均接受18F-FDG PET/CT显像、单侧髂骨骨髓穿刺活检.以骨髓穿刺活检组织病理学检查结果为参照,评价视觉比较法(髂骨骨髓FDG摄取高于正常肝脏组织)、骨髓最大标准摄取值(SUVmax)法(髂骨骨髓SUVmax≥2.5作为淋巴瘤骨髓受累的诊断阈值)、SUVmax比值法(髂骨骨髓SUVmax与正常肝脏组织SUVmax比值≥1作为淋巴瘤骨髓受累的诊断阈值)的诊断效能.结果 ①77例患者中男36例,女41例.Ann-Arbor分期I、Ⅱ、Ⅲ、Ⅳ期者分别为5、8、7、57例.②视觉比较法的诊断敏感性为100.00%,特异性为80.00%,阳性预测值为48.00%,阴性预测值为100.00%.③骨髓SUVmax法的诊断敏感性为75.00%,特异性为92.31%,阳性预测值为64.29%,阴性预测值为95.24%.④SUVmax比值法的诊断敏感度为100.00%,特异性为90.77%,阳性预测值66.67%,阴性预测值100.00%.结论 髂骨骨髓SUVmax与正常肝脏组织SUVmax比值≥1作为18F-FDG PET/CT的诊断阈值在DLBCL患者骨髓受累中具有良好的诊断价值. Objective To evaluate three methods of 18F-FDG PET/CT in detecting bone marrow infiltration in patients with newly diagnosed diffuse large B-cell lymphoma.Methods Seventy-seven patients with newly diagnosed diffuse large B-cell lymphoma from July 2012 to June 2014 were retrospectively analyzed.All patients received both 18F-FDG PET/CT scan and bone marrow biopsy in the region of the posterior iliac crests.There were three evaluation methods of 18F-FDG PET/CT to detect bone marrow infiltration,including visual comparison (the FDG uptake in bone marrow of iliac crests was higher than the normal liver tissue),the maximal standardized uptake values (SUVmax) in bone marrow of iliac crests (more than or equal to 2.5),the ratio of maximal standardized uptake values of iliac crests bone marrow to liver parenchyma intensity (more than 1).All results were compared with the bone marrow biopsy.Results Visual comparison of 18F-FDG PET/CT could be used to diagnose bone marrow infiltration,with the sensitivity of 100.00%,specificity of 80.00%,positive predictive value of 48.00%,and negative predictive value of 100.00%.When the SUVmax of iliac crests was used as the diagnostic threshold,the sensitivity was 75.00%,with 92.31% specificity,64.29% positive predictive value,and 95.24% negative predictive value.The ratio of SUVmax had the best diagnostic efficiency,with sensitivity of 100.00%,specificity of 90.77%,positive predictive value of 66.67%,and negative predictive value of 100.00%.Conclusions The ratio of SUVmax is a valuable diagnostic method in detecting diffuse large B-cell lymphoatic bone marrow involvement.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2015年第6期489-492,共4页 Chinese Journal of Hematology
关键词 正电子发射断层扫描及电脑断层扫描 淋巴瘤 大B细胞 弥漫性 肿瘤侵润 活组织检查 针吸 Positron-emission tomography and computed tomography Lymphoma, large B-cell,diffuse Neoplasm Invasiveness Biopsy, needle
  • 相关文献

参考文献11

  • 1Sun J, Yang Q, Lu Z, et al. Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification[J]. Am J Clin Pathol, 2012, 138(3): 429-434.
  • 2Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma[J]. Blood, 2007, 110(10):3507-3516.
  • 3Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification[J]. Blood, 2003, 101(10): 3875-3876.
  • 4Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography[J]. Blood, 1998, 91(9): 3340-3346.
  • 5Hong J, Lee Y, Park Y, et al. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma[J]. Ann Hematol, 2012, 91(5): 687-695.
  • 6Talaulikar D, Dahlstrom JE, Shadbolt B, et al. Role of immunohistochemistry in staging diffuse large B-cell lymphoma (DLBCL)[J]. J Histochem Cytochem, 2008, 56(10): 893-900.
  • 7刘恩彬,陈辉树,张培红,李占琦,孙琦,杨晴英,方立环,孙福军,孙瑞杰.弥漫性大B细胞淋巴瘤侵犯骨髓的病理学观察[J].白血病.淋巴瘤,2010,19(2):78-81. 被引量:7
  • 8Cheng G. Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate[J]. Ann Hematol, 2013, 92(2): 283-284.
  • 9Berthet L, Cochet A, Kanoun S, et al. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy[J]. J Nucl Med, 2013, 54(8): 1244-1250.
  • 10Khan AB, Barrington SF, Mikhaeel NG, et al. PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement[J]. Blood, 2013, 122(1): 61-67.

二级参考文献28

  • 1刘恩彬,陈辉树,邱录贵.淋巴瘤侵犯骨髓的病理与临床研究进展[J].诊断病理学杂志,2004,11(3):196-198. 被引量:21
  • 2陈辉树.淋巴瘤侵犯骨髓的诊断与鉴别诊断[J].白血病.淋巴瘤,2004,13(5):308-312. 被引量:16
  • 3刘恩彬,陈辉树,杨晴英,方立环,李占琦.非霍奇金淋巴瘤侵犯骨髓的病理形态及免疫表型特点分析[J].中国肿瘤临床,2005,32(16):923-927. 被引量:9
  • 4陈辉树.淋巴瘤侵犯骨髓的诊断[J].中国实用内科杂志:临床前沿版,2006,26(3):404-407. 被引量:8
  • 5Bangerter M, Moog F, Buchmann I, et al. FDG PET imaging in patients with lymphoma: a clinical perspective. J Nucl Med, 2001,42:609-610.
  • 6Jerusalem G, Warland V, Najjar F, et al. Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin' s disease and nonHodgkin' s lymphoma. Nucl Med Commun, 1999,20 : 13-20.
  • 7Hwang K, Park CH, Kim HC, et al. Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography. Clin Nucl Med, 2000, 25:789-795.
  • 8Tatsumi M, Kitayama H, Sugahara H, et al. Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin' s lymphoma. J Nucl Med, 2001,42:601-608.
  • 9Weihrauch MR, Re D, Bischoff S, et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin' s disease. Ann Hematol, 2002, 81 : 20 -25.
  • 10Elstrom R, Guan L, Baker G, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood, 2003, 101:3875- 3876.

共引文献13

同被引文献39

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部